Pay in 4 interest-free payments of $5.40 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Originally developed at Monash University as part of research into the lipolytic domain of hGH, AOD-9604 retains many of the fat-mobilising characteristics of full-length growth hormone while lacking the broader growth-promoting and insulin-resistance effects associated with the parent molecule
Retatrutide shows the highest weight loss in trials (28.7%), followed by tirzepatide (25%)
As of writing, 5-amino-1MQ is not approved for human use but is available as a research chemical for laboratory experimentation
(1) DNA synthesis Your body also needs B12 to form DNA (1)
Scientists and researchers have suggested that the modified portion of the hGH in the AOD 9604 peptide may be responsible for significantly inducing the fat burning process, possibly without stimulating the production of Insulin-like Growth Factor IGF 1, as opposed to the natural growth hormone
Received my product in a quick manner
US$ 20.40
US$ 21.64
US$ 21.46
US$ 24.38
US$ 29.29
